Richard A. Young

Insider Reports History

Entity
Individual
Location
C/O Syros Pharmaceuticals, Inc., 620 Memorial Drive Suite 300, Cambridge, Massachusetts
Signature
/s/ Todd Rosenthal, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard A. Young:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Syros Pharmaceuticals, Inc. Director Common Stock 8K $41K $5.12 Jun 28, 2024 Direct
Syros Pharmaceuticals, Inc. Director Restricted Stock Units 5.33K $11.8K $2.22 Sep 16, 2023 Direct
Omega Therapeutics, Inc. Director Stock Option (Right to Buy) 25K Jun 20, 2024 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 6K Jun 5, 2024 Direct

Insider Reports Filed by Richard A. Young

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SYRS Syros Pharmaceuticals, Inc. Jun 28, 2024 1 -$178K 4 Jul 2, 2024 Director
OMGA Omega Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Sep 16, 2023 2 $0 4 Sep 19, 2023 Director
OMGA Omega Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
OMGA Omega Therapeutics, Inc. Jun 2, 2023 1 -$40K 4 Jun 5, 2023 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2023 2 $0 4 Jun 2, 2023 Director
OMGA Omega Therapeutics, Inc. May 1, 2023 1 -$40K 4 May 3, 2023 Director
OMGA Omega Therapeutics, Inc. Apr 6, 2023 1 -$40K 4 Apr 10, 2023 Director
OMGA Omega Therapeutics, Inc. Mar 17, 2023 1 -$80K 4 Mar 20, 2023 Director
OMGA Omega Therapeutics, Inc. Jan 10, 2023 1 -$160K 4 Jan 11, 2023 Director
SYRS Syros Pharmaceuticals, Inc. Sep 16, 2022 2 $0 4 Sep 19, 2022 Director
OMGA Omega Therapeutics, Inc. Sep 14, 2022 1 -$80K 4 Sep 15, 2022 Director
OMGA Omega Therapeutics, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
OMGA Omega Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director, 10%+ Owner
SYRS Syros Pharmaceuticals, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director